Desco, Marí-Carmen <br/><br/>
Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol.  [electronic resource] 

 -  Diabetes  Apr 2002 
 - 1118-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0012-1797 
<br/><br/><label>Standard No.: </label>10.2337/diabetes.51.4.1118  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allopurinol--therapeutic use<br/>Animals<br/>Diabetes Mellitus, Experimental--physiopathology<br/>Diabetes Mellitus, Type 1--drug therapy<br/>Double-Blind Method<br/>Free Radical Scavengers--therapeutic use<br/>Free Radicals--metabolism<br/>Glutathione--metabolism<br/>Glutathione Disulfide--metabolism<br/>Heart--drug effects<br/>Humans<br/>Kinetics<br/>Lipid Peroxidation--drug effects<br/>Liver--drug effects<br/>Male<br/>Malondialdehyde--metabolism<br/>Membrane Potentials--drug effects<br/>Mitochondria, Heart--drug effects<br/>Myocardium--metabolism<br/>Oxidative Stress--drug effects<br/>Rats<br/>Rats, Wistar<br/>Xanthine Oxidase--antagonists & inhibitors